Navigation Links


erythematosus at medicine technology

Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease

...nts with autoimmunediseases such as systemic lupus erythematosus (SLE) andanti-phospholipid syndrome. The study looked at 113 SLE patients(94 with secondary anti-phospholipid syndrome and 19 without) andconcluded the measurement of anti-AtherOx is significantly betterthan conventional anti-cardiolipin testing in i...

Aspreva and Roche Announce Preliminary Results for Phase III Study Evaluating CellCept in Lupus Nephritis

...ry results. About Lupus Nephritis Systemic lupus erythematosus (SLE), commonly called lupus, is achronic autoimmune disease that causes the body to attack its owntissues and joints. Lupus nephritis, considered life-threatening,but rare, is the most serious manifestation of SLE. If leftuntreated, it can lead to k...

Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B Showed Significant Reductions in Disease Activity in Patients with Active Systemic Lupus Erythematosus

...lity of life inpatients with active systemic lupus erythematosus (SLE). The52-week and 76-week results of the Phase...About Systemic Lupus Erythematosus Systemic lupus erythematosus (SLE) is a chronic,life-threatening disease. The Lupus Foundation of America estimatesthat approxima...

ZymoGenetics Reports Results From Atacicept Phase 1b Clinical Trial in B-Cell Chronic Lymphocytic Leukemia

... certain autoimmunediseases such as systemic lupus erythematosus (SLE). Current dataindicates that levels of BLyS and APRIL are elevated in patientswith rheumatoid arthritis, SLE and B-cell malignancies. Atacicepthas been shown to affect several stages of B-cell development andmay inhibit the survival of cells res...

Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple Sclerosis Presented at the American Academy of Neurology

... certain autoimmune diseases such as systemiclupus erythematosus (SLE), an indication for which Rituxan has notbeen approved. About Rituxan Rituxan is a therapeutic antibody being studied in primaryprogressive MS, for which there is currently no FDA-approvedtherapy. Rituxan is also being studied in other autoim...

Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple Sclerosis Presented at the American Academy of Neurology

... certain autoimmune diseases such as systemiclupus erythematosus (SLE), an indication for which Rituxan has notbeen approved. About Rituxan Rituxan is a therapeutic antibody being studied in primaryprogressive MS, for which there is currently no FDA-approvedtherapy. Rituxan is also being studied in other autoimm...

Cellerant Therapeutics Reversed Autoimmune Disease in Lupus Mice with Transplant of Purified Donor Blood Stem Cells

...d autoimmune disease. About Lupus Systemic lupus erythematosus (SLE), also called lupus, is anautoimmune disorder characterized by the immune system attackingthe body's own tissues and organs, leading to inflammation anddamage. The severity of the disease varies, from mild cases onlyinvolving the skin to severe ...

Study: Identical Doses of BiDil Components Are Not Bioequivalent to the Fixed Dose Combination-BiDil-Used in A-HeFT

...roduce a clinical picturesimulating systemic lupus erythematosus (SLE) includingglomerulonephritis. If SLE-like symptoms occur, discontinuation ofBiDil should be considered. Residua have been detected many yearsafter discontinuation of hydralazine. Symptomatic hypotension mayoccur with even small doses of BiDil. B...

La Jolla Pharmaceutical Provides Update on Interim Antibody Results From Riquent Lupus Phase 3 Trial

... drug candidate for the treatmentof systemic lupus erythematosus ("lupus"), and any other drugcandidate that we may develop, including the results of any trialsor models that are ongoing or that we may initiate in the future,could result in a finding that these drug candidates are noteffective in large patient pop...

La Jolla Pharmaceutical Announces Positive Interim Antibody Results From Riquent Lupus Phase 3 Trial

...imus sodium), its drugcandidate for systemic lupus erythematosus ("lupus" or "SLE").Analyses of interim antibody da... drug candidate for the treatmentof systemic lupus erythematosus ("lupus"), and any other drugcandidate that we may develop, including the results of any trialsor mo...
Other Contentsjointjointjointjointjointjointjointjointkaryotypekeratinkeratinkeratinkidneykidneykidneykidneykidneykidneykidneykidneykidneykinesiologykinetickinetickinetickinetickinetic
(Date:7/23/2008)...io Wealthy nations willing to collectively spend ...on of roughly half a billion metric tons of carbon...rch suggests. , It would take about that much m...restation in the world, one of the top contributor...e. , If adopted, this type of program could have...
(Date:7/23/2008)...d summit" will bring together internationally reno....S., Russia, China, Japan, Australia and India to... to Aug. 2. , "We are bringing together the w...e," said summit organizer J. William Schopf, found...s and Planetary Physics, Center for the Study of E...
(Date:7/23/2008)...t the National Institute of Standards and Technolo...e formation of clumps of proteins in protein-based...rifies the conditions under which scientists can b...asuring the formation of protein aggregates, a maj...l and safety in biologic drug manufacturing. , P...
(Date:7/23/2008)... scientists who set out to study sex pheromones in...nes also controls a stage in the worms, life cycle...published in Nature online on July 23, represent...e been linked through so-called small molecules. ...eins as the major players in an organism,s biology...
Breaking Biology News(10 mins):Paying to save tropical forests could be a way to reduce global carbon emissions 2Paying to save tropical forests could be a way to reduce global carbon emissions 3Paying to save tropical forests could be a way to reduce global carbon emissions 4UCLA 'world summit' to explore ancient life on Earth, and beyond 2NIST trumps the clumps: Making biologic drugs safer 2Sex and lifespan linked in worms 2Under the Canopy 28R 29 Turns a New Leaf With 2008 Spring Season 13696 1Under the Canopy 28R 29 Turns a New Leaf With 2008 Spring Season 13696 2Medco Tops Fortunes List of Americas Most Admired Companies in its Industry 13692 1Medco Tops Fortunes List of Americas Most Admired Companies in its Industry 13692 2Medco Tops Fortunes List of Americas Most Admired Companies in its Industry 13692 3Biking Walking Best for New Knees 13688 1Biking Walking Best for New Knees 13688 2Biking Walking Best for New Knees 13688 3ProMetic reports continued positive data in PBI 1402 phase II trial in chemotherapy induced anemia 3764 1ProMetic reports continued positive data in PBI 1402 phase II trial in chemotherapy induced anemia 3764 2ProMetic reports continued positive data in PBI 1402 phase II trial in chemotherapy induced anemia 3764 3
(Date:7/25/2008)... to benefit ALS Therapy Alliance to be presented a...ht, WOONSOCKET, R.I., July 25 /PRNewswire/ -- CVS...ised a record-breaking $4.4 million in just 21 day... for ALS research. This is,the seventh year of the...sed more than $15 million for ALS research. This y...
(Date:7/25/2008)...ds fluid back-up in esophagus can cause immune sys...ay News) -- The first evidence linking gastroesoph...scovered by Duke University Medical Center researc...ns was first noted in the 1970s, and since then st...rcent of asthma patients also experience GERD symp...
(Date:7/25/2008)... New program delivers immediate co...[24-hour telephone access to language interpreters...g multilingual solutions. , ...LLE® http://www.lle-inc.com/index.html [(Lan...ider of interpretation, translation, and language ...
(Date:7/25/2008)... Whether you are an Olympian, Prof..., there are Five Things You Need to Know about Hyd....C. Spine and Sports Center , ...-- America,s premier athletes are heading to Beiji...ng and sacrifice in the hopes of capturing an Olym...
Breaking Medicine News(10 mins):Health News:CVS/pharmacy Raises Record-breaking $4.4 Million for ALS Research Through Annual ALS Fundraising Campaign 2Health News:People With GERD More Likely to Develop Asthma 2Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 2Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 3Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 2Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 3Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 4Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 5
Other TagsOutbreakOutbreakOvulationOther Tagsworthwhile 2worthwhile 3testicular 2testicular 3snacks 2snacks 3macular 2macular 3macular 4macular 5fast 2fast 3fast 4fast 5fast 6fast 7fast 8fast 9fast 10healthier 2gone 2gone 3gone 4keeping 2keeping 3keeping 4keeping 5keeping 6